Navitor Adverse Events: FDA MAUDE Data

ABBOTT (ST. JUDE MEDICAL) · Transcatheter Aortic Valve (TAVR) · First cleared Sep 2021 · 12 device variants grouped

Total Reports

3,538

Reports (30d)

133

Active Signals

0

Open Recalls

5

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Death Following Tricuspid Surgery Post-ImplantEmerging

registry, implant sapien, sapien ultra, ultra resilia, ultra

1

reports

2

Successful Implant with No Complications

non abbott, vision valve, flexnav, flexnav delivery, navitor

235

reports

3

Literature Batch: Self-Expanding Valve Outcomes

evolut, patients, study, tavi, included

16

reports

4

Heart Block Requiring Pacemaker Post-Implant

pacemaker, did, registry, navitor vision, vision valve

13

reports

5

Balloon Rupture During Valve-in-Valve Procedure

ultra, clinical specialist, specialist, sapien ultra, resilia valve

2

reports

6

Transient Bradycardia During Pre-Implant BAV

dcs, non medtronic, tav, bioprosthetic, balloon

2

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

FDA recalls for this device

Class II

Oct 17, 2024 · Open, Classified

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Class II

Oct 17, 2024 · Open, Classified

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Class II

Oct 17, 2024 · Open, Classified

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Class II

Oct 17, 2024 · Open, Classified

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Class II

Oct 17, 2024 · Open, Classified

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.